[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"restenosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:restenosis":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100591350","intravascular-ultrasound-for-peripheral-artery-disease-revascularization-100591350",false,"NCT06979284","Intravascular Ultrasound for Peripheral Artery Disease Revascularization","Intravascular Ultrasound for Peripheral Artery Disease Revascularization: The CLARITY Randomized Controlled Trial","CLARITY","Inclusion Criteria:\n\n1. Patients presenting with lower extremity PAD manifesting as CLTI:\n\n   a. CLTI is defined as ischemic rest foot pain, nonhealing wounds, or gangrene present for at least two weeks and that is attributable to objectively proven arterial occlusive disease, compatible with Rutherford class 4, 5 or 6, with the following supporting hemodynamic criteria1: i. For ischemic rest pain (Rutherford category 4): Ankle systolic pressure \\\u003C 40mmHg, toe pressure \\\u003C 30mmHg, or flat-line transtarsal pulse volume recording, OR ii. For tissue loss (Rutherford category 5, 6): Ankle systolic pressure \\\u003C 60 mmHg, toe pressure of \\\u003C 40mmHg, or flat-line transtarsal volume recording, AND\n2. Scheduled to undergo percutaneous revascularization, AND\n3. Informed consent\n4. Imaging evidence of an obstructive or occluded lesion (\\> 70%) in the infraiguinal circulation (e.g. femoral, popliteal, or infrapopliteal circulation) using angiography, ultrasound, computed tomography, or magnetic resonance imaging.\n5. An infrapopliteal lesion must be located in the proximal 2\u002F3 of native infrapopliteal vessels, with a vessel diameter of \\> 2.5mm by investigator visual assessment.\n6. The distal margin of the most distal target lesion must be located \\> 10 cm proximal to the proximal margin on the ankle mortise. The vessel segment distal to the most distal target lesion must be patent all the way to the ankle, with no obstructive lesion (\\>50% stenosis).\n\nExclusion Criteria:\n\n1. The presence of anatomic or comorbid conditions or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the potential participant's ability to participate in the trial or to comply with the follow-up requirements.\n2. The presence of any medical conditions precluding percutaneous revascularization\n3. The subject has previously had or requires surgical revascularization involving the vessel containing the target lesion of the ipsilateral extremity.\n4. The subject is bedridden or unable to walk (with assistance is acceptable).\n5. Life expectancy \\\u003C 12 months\n6. Age \\\u003C 18 years\n7. Active vasculitis, Buerger's disease, or acute limb-threatening ischemia\n8. Planned above-ankle amputation of the index limb within four weeks of the index procedure.\n9. Obstructive supra-inguinal \"inflow\" (\\>70% stenosis) which is not planned to be treated during index procedure or within 30 days of the index procedure.\n10. The subject has had any amputation to the ipsilateral extremity other than the toe or forefoot, or the subject has had a major amputation to the contralateral extremity \\\u003C 1 year before the index procedure and is not independently walking.\n11. Extensive tissue loss that is salvageable only with complex foot reconstruction or non-traditional trans metatarsal amputations.\n\n    1. Osteomyelitis that extends proximal to the metatarsal heads\n    2. Gangrene involving the plantar skin of the forefoot, midfoot or heel\n    3. Deep ulcer or large shallow ulcer (\\> 3 cm) involving the plantar skin of the f forefoot, midfoot, or heel\n    4. Full-thickness heel ulcer\n    5. Any wound with calcaneal bone involvement\n    6. Wounds that would require flap coverage or complex wound management for large soft tissue defect\n    7. Full-thickness wounds on the dorsum of the foot with exposed tendon or bone.","ALL","18 Years",{"count":20,"type":21},772,"ESTIMATED","INTERVENTIONAL",[24],"NA","The purpose of this study is to determine if IVUS use, as compared to angiography alone, prevent major adverse limb events (MALE) or binary restenosis (a greater than 50% re-narrowing of the treated artery) in adult patients who have CLTI and are undergoing percutaneous revascularization.",[27,28,29,30,31],"Peripheral Arterial Disease(PAD)","Chronic Limb Threatening Ischemia","Intravascular Ultrasound","Major Adverse Limb Events","Restenosis","RECRUITING","2026-06-04",{"date":35,"type":36},"2026-06-08","ACTUAL",{"date":38,"type":36},"2025-12-05",{"date":40,"type":21},"2030-10",{"name":42,"class":43},"Hamilton Health Sciences Corporation","OTHER",{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":22,"phases":53,"briefSummary":54,"conditions":55,"keywords":68,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":5},"100617275","optimal-strategy-to-correct-stent-underexpansion-in-resistant-lesions-100617275","NCT07316504","Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions","OSCAR","Inclusion criteria :\n\n* Patient who have undergone coronary angiography with ISR, defined as ≥50% reduction of the diameter of the intrastent lumen occurring ≥ 6 months after stent implantation\n* And with a suspicion of stent under-expansion on angiography, possibly assisted by a stent enhancement technique\n* The reference diameter of the target vessel must be ≥2.5 mm and ≤5.0 mm.\n* Coronary flow must be TIMI 3\n* Ability to cross the lesion with the OCT catheter (possibly after predilatation with a balloon up to 2 mm)\n* Patient affiliated to the French National Health Insurance\n\nExclusion criteria :\n\n* Heart failure with NYHA III or IV (or cardiogenic shock)\n* LVEF \\\u003C20%\n* Chronic renal failure with clearance \\\u003C30mL\u002Fmn according to CKD\n* Pregnant or breast-feeding women\n* Patient with a condition\u002Fcomorbidity that could reduce compliance with the protocol, including pre-specified study follow-up\n* Patient participating in another ongoing medical study evaluating a pharmacological or biological agent or medical device, unless authorized by the concomitant protocol.\n* Patient unable to tolerate double antiaggregation (i.e., aspirin and clopidogrel or prasugrel or ticagrelor) for at least 6 months.\n* Possible or defined thrombus (by angiography or endovascular imaging) in the target vessel.",{"count":52,"type":21},80,[24],"Percutaneous coronary intervention (PCI) for in-stent restenosis (ISR) accounts for 5-10% of PCI. ISR may be linked to mechanical complications mainly under-expansion (UE), neointimal hyperplasia and\u002For neoatherosclerosis. International guidelines recommends non-compliant and very-high-pressure balloons, which lead to sub-optimal angiographic and clinical results. Recently, observational studies have suggested the feasibility and safety of intravascular lithotripsy (IVL) in UE treatment. There are no prospective randomised controlled studies comparing intravascular lithotripsy with balloons in ISR with UE.",[56,31,57,58,59,60,61,62,63,64,65,66,67],"Coronary Angioplasty","Lithotripsy","Restenosis of Coronary Artery Stent","Angioplasty, Transluminal, Percutaneous Coronary","Percutaneous Coronary Intervention (PCI)","OCT Angiography","Optical Coherence Tomography (OCT)","Intravascular Lithotripsy; Rotational Atherectomy; OFDI","Intravascular Lithotripsy","Coronary Artery Disease","Coronary Artery Disease (CAD)","Coronary Stent Restenosis",[69,70,71,72,73,74,75],"restenosis","underexpansion","intrastent restenosis","randomized clinical trial","intravascular lithotripsy","baloon PCI","Percutaneous coronary intervention","2025-12-18",{"date":78,"type":36},"2026-01-05",{"date":80,"type":36},"2025-10-22",{"date":82,"type":21},"2031-09",{"name":84,"class":43},"University Hospital, Clermont-Ferrand"]